SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-058749
Filing Date
2023-05-11
Accepted
2023-05-11 07:25:06
Documents
14
Period of Report
2023-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2315317d1_8k.htm   iXBRL 8-K 26088
2 EXHIBIT 99.1 tm2315317d1_ex99-1.htm EX-99.1 70279
6 GRAPHIC tn2315317d1_ex99-1img001.jpg GRAPHIC 5977
  Complete submission text file 0001104659-23-058749.txt   294952

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mist-20230511.xsd EX-101.SCH 3054
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mist-20230511_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mist-20230511_pre.xml EX-101.PRE 22609
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2315317d1_8k_htm.xml XML 3875
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38899 | Film No.: 23908819
SIC: 2834 Pharmaceutical Preparations